Brimonidine Tartrate Solution/ Drops
Product Images NDC 70069-568

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 70069-568). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5a808f88 Afeb 4ab3 B005 56b68b27dc7f 01)

Chemical structure diagram of brimonidine tartrate, showing its molecular components and configuration as represented in the product data for BRIMONIDINE TARTRATE 1 mg/mL ophthalmic solution.*

FDA Label Image

Bottle-label-5ml (5a808f88 Afeb 4ab3 B005 56b68b27dc7f 02)

This label text for Brimonidine Tartrate Ophthalmic Solution 0.1% describes the usual dosage as one drop three times daily to the affected eye(s). It includes storage instructions at 15°-25°C and notes the bottle is filled to half capacity. The label states the product is sterile, manufactured by Somerset Therapeutics, LLC, made in India, and shows the NDC code 70069-566-01 along with a barcode.*

FDA Label Image

Image (5a808f88 Afeb 4ab3 B005 56b68b27dc7f 03)

Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.1%, an ophthalmic solution in a 5 mL bottle. The label includes the NDC number 70069-566-01, identifies the product as sterile, and lists the manufacturer as Somerset Therapeutics LLC. The label also provides a list of active and inactive ingredients.*

FDA Label Image

Image (5a808f88 Afeb 4ab3 B005 56b68b27dc7f 04)

Dosage and storage information panel for Brimonidine Tartrate Ophthalmic Solution 0.1%, manufactured by Somerset Therapeutics, LLC. The panel includes usual dosage instructions, storage temperature, NDC code 70069-567-01, and mentions the product is sterile and made in India. It also includes a barcode and a note about area blank and varnish-free printing.*

FDA Label Image

Image (5a808f88 Afeb 4ab3 B005 56b68b27dc7f 05)

Carton label for Brimonidine Tartrate Ophthalmic Solution 0.1% sterile 10 mL drops by Somerset Therapeutics LLC. The label includes the active ingredient concentration, active and inactive ingredients list, storage instructions, and usual dosage information. Features the Somerset Therapeutics LLC logo and barcodes. Manufactured in India.*

FDA Label Image

Image (5a808f88 Afeb 4ab3 B005 56b68b27dc7f 06)

Label for Brimonidine Tartrate Ophthalmic Solution 0.1%, a sterile eye drop manufactured for Somerset Therapeutics, LLC. The label shows a 15 mL bottle containing Brimonidine tartrate 0.1% with preservative iPRES 25. Directions state one drop three times daily. Storage recommended at 15°-25°C (59°-77°F). Made in India.*

FDA Label Image

Image (5a808f88 Afeb 4ab3 B005 56b68b27dc7f 07)

Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.1%, sterile, 15 mL. The label includes the product name, concentration, and volume, along with the active ingredient listed as Brimonidine tartrate 0.1%, and several inactive ingredients. It is manufactured for Somerset Therapeutics, LLC. The label also displays the NDC number 70069-568-01 and has storage instructions. The Somerset Therapeutics logo is shown at the bottom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.